{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:22:53Z","timestamp":1793258573703,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17OC0029510"],"award-info":[{"award-number":["NNF17OC0029510"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ahj.2021.08.020","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T01:10:49Z","timestamp":1631841049000},"page":"28-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial"],"prefix":"10.1016","volume":"243","author":[{"given":"Kasper","family":"Korsholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Damgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-7179","authenticated-orcid":false,"given":"Jan Brink","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5357-066X","authenticated-orcid":false,"given":"Erik Jerome Stene","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Odenstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0169-5137","authenticated-orcid":false,"given":"Juha","family":"Sinisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Putaala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halvor","family":"N\u00e6ss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ahmad","family":"Al-Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Erik","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Pontoppidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4331-4491","authenticated-orcid":false,"given":"Boris","family":"Modrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Hjort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina Laut","family":"Matzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Paaske","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Erik","family":"Nielsen-Kudsk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2021.08.020_bib0001","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/CLEP.S47385","article-title":"Epidemiology of atrial fibrillation: european perspective","volume":"6","author":"Zoni-Berisso","year":"2014","journal-title":"CLEP"},{"key":"10.1016\/j.ahj.2021.08.020_bib0002","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"361","author":"Lippi","year":"2020","journal-title":"Int J Stroke"},{"key":"10.1016\/j.ahj.2021.08.020_bib0003","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2021.08.020_bib0004","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1161\/STROKEAHA.114.006070","article-title":"High prevalence of atrial fibrillation among patients with ischemic stroke","volume":"45","author":"Friberg","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2021.08.020_bib0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","article-title":"Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study","volume":"36","author":"Marini","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2021.08.020_bib0006","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2021.08.020_bib0007","first-page":"157","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"20","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.08.020_bib0008","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.08.020_bib0009","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran vs warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.08.020_bib0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban vs warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.08.020_bib0011","doi-asserted-by":"crossref","unstructured":"Cunningham M, Giugliano R. Edoxaban noninferior to warfarin in the ENGAGE AF-TIMI 48 Trial. MD Conference Express 2013;13:24-25. doi:10.1177\/155989771320012.","DOI":"10.1177\/155989771320012"},{"key":"10.1016\/j.ahj.2021.08.020_bib0012","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ahj.2021.08.020_bib0013","first-page":"899","article-title":"Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark","volume":"38","author":"Gadsb\u00f8ll","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.08.020_bib0014","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bcpt.12664","article-title":"Treatment changes among users of non-vitamin k antagonist oral anticoagulants in atrial fibrillation","volume":"120","author":"Hellfritzsch","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ahj.2021.08.020_bib0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ehjcvp\/pvw048","article-title":"Adherence with oral anticoagulation in non-valvular atrial fibrillation: a comparison of vitamin K antagonists and non-vitamin K antagonists","volume":"3","author":"S\u00f8rensen","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.ahj.2021.08.020_bib0016","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2021.08.020_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.08.020_bib0018","doi-asserted-by":"crossref","first-page":"0735","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.08.020_bib0019","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.08.020_bib0020","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2021.08.020_bib0021","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"issue":"7","key":"10.1016\/j.ahj.2021.08.020_bib0022","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4244\/EIJ-D-17-00493","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical\/echocardiographic data from a global prospective observational study","volume":"13","author":"Landmesser","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2021.08.020_bib0023","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/heartjnl-2016-309782","article-title":"Efficacy and safety of left atrial appendage closure vs medical treatment in atrial fibrillation: a network meta-analysis from randomised trials","volume":"103","author":"Sahay","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2021.08.020_bib0024","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jcin.2017.06.057","article-title":"Intracardiac echocardiography from the left atrium for procedural guidance of transcatheter left atrial appendage occlusion","volume":"10","author":"Korsholm","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2021.08.020_bib0025","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4244\/EIJ-D-16-00726","article-title":"Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy","volume":"12","author":"Korsholm","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2021.08.020_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008112","article-title":"Detection of device-related thrombosis following left atrial appendage occlusion: a comparison between cardiac computed tomography and transesophageal echocardiography","volume":"12","author":"Korsholm","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2021.08.020_bib0027","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.08.020_bib0028","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.amjcard.2005.01.049","article-title":"Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials","volume":"95","author":"Serebruany","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2021.08.020_bib0029","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2021.08.020_bib0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The danish national patient registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"CLEP"},{"key":"10.1016\/j.ahj.2021.08.020_bib0031","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ahj.2021.08.020_bib0032","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/01.hjr.0000239466.26132.f2","article-title":"The validation of the finnish hospital discharge register and causes of death register data on stroke diagnoses","volume":"14","author":"Tolonen","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ahj.2021.08.020_bib0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1403494819859737","article-title":"The norwegian patient registry and the norwegian registry for primary health care: research potential of 2 nationwide health-care registries","volume":"48","author":"Bakken","year":"2020","journal-title":"Scand J Public Health"},{"issue":"13","key":"10.1016\/j.ahj.2021.08.020_bib0034","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2021.08.020_bib0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcin.2019.08.054","article-title":"Expert recommendations on cardiac computed tomography for planning transcatheter left atrial appendage occlusion","volume":"13","author":"Korsholm","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2021.08.020_bib0036","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcin.2020.10.034","article-title":"Peridevice leak following amplatzer left atrial appendage occlusion: cardiac computed tomography classification and clinical outcomes","volume":"14","author":"Korsholm","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2021.08.020_bib0037","first-page":"229","article-title":"Cardiac computed tomography for left atrial appendage occlusion: acquisition, analysis, advantages, and limitations","volume":"7","author":"Korsholm","year":"2018","journal-title":"Interv Cardiol Clin"},{"key":"10.1016\/j.ahj.2021.08.020_bib0038","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4244\/EIJV12I1A18","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies","volume":"12","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.ahj.2021.08.020_bib0039","doi-asserted-by":"crossref","DOI":"10.1177\/2396987321992905","article-title":"European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack","volume":"6","author":"Fonseca","year":"2021","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.ahj.2021.08.020_bib0040","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"Easton","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2021.08.020_bib0041","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the watchman left atrial appendage closure technology","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032100226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032100226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:59:03Z","timestamp":1762077543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287032100226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":41,"alternative-id":["S000287032100226X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2021.08.020","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2021.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}